Defiance Daily Target 2x (SMST) Q1 2024 Earnings Report

SMST reported results for QQ1 2024 with revenue of USD 57.04 million and a positive operating income of USD 16.00 million, yet a net loss of USD 4.65 million. Operating profitability improved versus a prior period on an absolute basis (operating income +51.17% YoY; +5.74% QoQ decline in operating margin), but the bottom line remained pressured by significant non-operating costs: total other income and expenses net declined by USD 20.99 million and a large interest expense of USD 16.55 million contributed to an after-tax loss. EBITDA stood at USD 16.00 million, resulting in an EBITDAR of approximately 28.05%. Free cash flow and cash from operations were positive (FCF and CFO both USD 14.41 million), supporting liquidity despite the quarterly net loss. Balance sheet shows substantial assets (USD 1.89 billion) and a robust stockholders’ equity foundation (USD 384.8 million) with a net debt position of negative USD 39.16 million. The company also exhibits a high price-to-book and price-to-sales multiple, consistent with the niche, complexity-rich profile of leveraged/inverse ETFs. Management commentary for the QQ1 2024 period is not available in the provided transcript dataset, so direct quotes could not be incorporated. Investors should heed the inherent risks of 15x inverse daily exposure, including compounding effects and potential divergences from long-horizon performance, which are not explicitly guided in the filing.